An update of 77 cases diagnosed as oral hemangiomas based on GLUT-1 positivity

Abstract

ObjectivesTo evaluate cases diagnosed as “oral hemangiomas” based on the immunohistochemical expression of human glucose transporter protein (GLUT-1) and on histopathological features, and to investigate whether the classification proposed by the ISSVA was used correctly to classify these lesions. Material and methodsAll cases stored in the archives of an Oral Pathology Service and diagnosed as “oral hemangiomas” were reviewed. Seventy-seven cases were analyzed regarding the expression of GLUT-1. GLUT-1(+) specimens were classified as true infantile hemangioma (IH) and GLUT-1(−) specimens were reclassified based on their histopathological features. The nomenclature of these lesions was evaluated and some cases were reclassified. ResultsOnly 26 (33.8%) of the specimens were indeed IHs. Among the GLUT-1(−) specimens, 20 (26.0%) were reclassified as pyogenic granulomas (PGs) and 31 (40.2%) as vascular malformations. Considering the previously applied nomenclature, only 47.5% of the cases initially diagnosed as “hemangiomas” were IHs. In the group of “capillary hemangiomas”, most cases (56.2%) were PGs. Among the three “cellular hemangiomas”, two were PGs and one was IH. Most (88.8%) “cavernous hemangiomas” were vascular malformations. ConclusionCareful and parameterized review of cases of vascular anomalies is necessary using auxiliary tools such as GLUT-1, since the exclusive use of histopathological findings might be insufficient to differentiate some anomalies. Clinical relevanceAccurate clinical examination and the use of biomarkers such as GLUT-1 are essential for the diagnosis.